Autotransfusion Devices Market - By Product (Autotransfusion [Intraoperative, Post-operative, Dual-mode], Consumables & Accessories), Application (Cardiovascular, Orthopedic, Organ Transplantation), End-use (Hospitals, ASC) – Global Forecast, 2024 – 2032
Report ID: GMI8266
|
Published Date: February 2024
|
Report Format: PDF
Download Free PDF
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2023
Companies covered: 11
Tables & Figures: 241
Countries covered: 22
Pages: 110
Download Free PDF

Autotransfusion Devices Market
Get a free sample of this reportGet a free sample of this report Autotransfusion Devices Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Autotransfusion Devices Market Size
Autotransfusion Devices Market size was valued at around USD 514.6 million in 2023 and is anticipated to register a CAGR of 6.2% between 2024 and 2032. This robust market growth can be attributed to various factors, including ongoing advancements in technology, surging need for point-of-care testing (POCT) technologies, increasing demand for complex surgical procedures, growing demand for minimally invasive surgical techniques, and the continual growth of healthcare expenditure, among other contributing factors.
Moreover, the global growing trend toward an aging population highlights the importance to address age-related health issues such as anaemia, coagulopathy, and surgical bleeding risk. Autotransfusion devices provide a customized strategy to blood management in the elderly, improving perioperative care and lowering the burden of transfusion-related problems in this vulnerable group.
For instance, according to a recent United Nations (UN) research, the number of people aged 65 and over globally is predicted to treble over the next three decades. The senior population is expected to reach 1.6 billion by 2050, accounting for more than 16% of the worldwide population.
Furthermore, an increasing demand for sophisticated surgical operations such as cardiovascular surgery, organ transplantation, and oncology requires the growth of suitable blood management systems. Autotransfusion systems assist in controlling intraoperative blood loss and hemostasis in difficult surgical situations, improving surgical results and patient recovery, thereby contributing to the market growth.
Autotransfusion devices are medical instruments designed to collect, process, and reinfuse a patient's own blood during surgical procedures or following significant blood loss. These devices facilitate the recovery and reuse of the patient's own blood, minimizing the need for allogeneic (donor) blood transfusions and reducing the risk of transfusion-related complications.
Autotransfusion Devices Market Trends
The market is experiencing several notable trends that are shaping its growth and development. Factors such as continuous technological advancements in autotransfusion devices, growing trend towards miniaturization and portability, and a surging demand for integrated imaging and surgical navigation systems, among other factors are propelling the industry growth.
Autotransfusion Devices Market Analysis
The market by product is categorized into autotransfusion systems and consumables & accessories. The autotransfusion systems segment is further divided into intraoperative autotransfusion systems, post-operative autotransfusion systems, and dual-mode autotransfusion systems. The autotransfusion systems segment garnered USD 394.6 million revenue in 2023.
Based on application, the autotransfusion devices market is segmented into cardiovascular surgeries, orthopedic surgeries, organ transplantations, general surgeries, and other applications. The cardiovascular surgeries segment accounted for 33.8% business share in 2023 and is anticipated to witness significant growth.
The autotransfusion devices market by end-use is categorized into hospitals, ambulatory surgical centers, and other end-users. The hospitals segment accounted for around USD 310.9 million revenue size in 2023.
North America autotransfusion devices market accounted for USD 211.7 million revenue in 2023 and is predicted to witness substantial market progress.
Autotransfusion Devices Market Share
The autotransfusion devices industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players including BECTON, DICKINSON AND COMPANY, Fresenius SE & Co. KGaA, LivaNova, Inc., Medtronic plc, Teleflex Incorporated, among others have a notable presence in the market.
Autotransfusion Devices Market Companies
Some of the eminent market participants operating in the autotransfusion devices industry include:
Autotransfusion Devices Industry News:
Autotransfusion devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Product
Market, By Application
Market, By End-use
The above information is provided for the following regions and countries: